Breakout attempt at $39.02 resistance. Can Hims & Hers Health stock extend gains?

Traders Union
All News
Financial News
Hims & Hers Health jumps 5.75% today

Highlights

HIMS/USD demonstrates strong bullish momentum, trading above all major moving averages and showing robust longer-term support.
Momentum and oscillator indicators, including MACD, ADX, and RSI, all confirm continued strong buyer dominance with overbought conditions.
The price is expected to consolidate between $35.32 and $39.02, with a high probability of further upside and very low downside risk in the near term.

Bullish technicals persist as support holds amid elevated volatility

On the hourly chart, HIMS is trading above both its MA-20 at $35.46 and MA-50 at $35.58, while also well above the MA-200 on the daily timeframe at $31.91. The Ichimoku Kijun provides immediate support at $35.49. Momentum is strong, with bullish readings from both the Moving Average Convergence Divergence (MACD) and the Average Directional Index (ADX), indicating persistent buyer interest. The Relative Strength Index (RSI) stands at 66.84, suggesting a buy signal, while the Stochastic RSI and Commodity Channel Index (CCI) are each in overbought territory. Bull/Bear Power reflects buyer dominance, and the Awesome Oscillator confirms the upward bias. There are no material divergences between price action and the main indicators, with volatility remaining elevated.

Upside outlook prevails as consolidation risks lessen

For the short term, the projected price band for HIMS ranges from $35.32 to $39.02. The probability of continued upside is classified as very high, while the chance of a downside move is very low. The baseline expectation is for HIMS to consolidate within this channel; a breakout above resistance could drive prices towards the upper end of the range, whereas a breakdown below immediate support would be required to trigger any bearish scenario.

Viktoras Karapetjanc, expert at Traders Union, sees Hims & Hers Health maintaining strong upside momentum, supported by clear technical signals and persistent buyer interest. The analyst finds the lack of news irrelevant in light of robust sentiment and steady institutional demand seen in price action. Karapetjanc assesses the probability of further gains as very high while downside risk stays minimal in the current price channel. "Momentum remains decisive here — I expect buyers to push HIMS toward the $39.02 upper range in the near term," he states.

Earlier, analysts noted that Hims & Hers Health was enjoying sustained bullish momentum supported by favorable technical signals. The latest data reinforces this positive outlook, with elevated momentum indicators and solid support levels suggesting that traders should monitor for a breakout above the current consolidation channel as a potential catalyst for further gains.

Source of Data: HIMS Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.